Coronavirus Infection Prevention by Wearing Masks
Yıl: 2020 Cilt: 52 Sayı: 2 Sayfa Aralığı: 197 - 201 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2020.20056 İndeks Tarihi: 03-12-2020
Coronavirus Infection Prevention by Wearing Masks
Öz: The coronavirus disease 2019 (COVID-19) [2019-nCoV; severe acute respiratory syndrome coronavirus2 (SARS-CoV-2)] was first detected in Wuhan, China at the end of 2019. In current status, spread of COVID-19 in person-to-person could be caused mainly by respiratory droplets, which leads to the spread ofthe influenza virus in both community and clinicians. Thus, in order to reduce the risk of that, the urgentmanagement strategies against COVID-19 are to block transmission, isolation, protection, and using drug orvaccine updated on an ongoing basis. unfortunately, no drugs or vaccines still has yet been allowed to treatpatients with COVID-19, so the rapid detection of effective intercessions against COVID-19 is seemed amajor challenge on the all world. Herein, this article attempts summarizing to introduce the characterizationof COVID-19, the influence of droplets travel in person-to-person transmission and the effect of wearingmasks in the infection prevention of influenza virus, as well as understanding its advantage and role in thecoronavirus infection prevention.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Horcajada JP, Pumarola T, Martinez JA, et al. A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur Respir J 2003; 21: 303-7. [Crossref]
- 2. Dawood FS, Jain S, Finelli L, et al. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, New Engl J Med 2009; 360: 2605-15. [Crossref]
- 3. Cohen J, Enserink M. SWINE FLU After Delays, WHO Agrees: The 2009 Pandemic Has Begun. Science 2009; 324: 1496-7. [Crossref]
- 4. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459: 931-9. [Crossref]
- 5. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003; 361: 1761-6. [Crossref]
- 6. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 2020; 38: 727-33. [Crossref]
- 7. Lu HZ, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020: 92: 401-2. [Crossref]
- 8. Hui DS, Azha EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020: 91: 264-6. [Crossref]
- 9. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020; 395: 496. [Crossref]
- 10. Su S, Wong G, Shi WF, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016; 24: 490-502. [Crossref]
- 11. Diagnosis and treatment of new coronavirus pneumonia (version 5)’, National Health Commission of the People’s Republic of China, 2020. Available From: URL: http://www.nhc.gov.cn/.
- 12. Phan LT, Nguyen TV, Luong QC, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med 2020; 382: 872-4. [Crossref]
- 13. Holshue ML. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020; 382: 929-36. [Crossref]
- 14. Chan JFW, Yuan SF, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514-23. [Crossref]
- 15. Cohen, J. Wuhan seafood market may not be source of novel virus spreading globally’, 2020. Available From: URL: https://www.sciencemag.org/news/2020/2001/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally [Crossref]
- 16. Carlos WG, Dela Cruz CS, Cao B, et al. Novel Wuhan (2019-nCoV) Coronavirus. Am J Resp Crit Care 2020; 201: 7-8. [Crossref]
- 17. Yoo JH. The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just Begun. J Korean Med Sci 2020; 35: e56. [Crossref]
- 18. Gao NP, Ni JL. Transient CFD simulation of the respiration process and inter-person exposure assessment Build Environ 2006; 41: 1214-22. [Crossref]
- 19. Gupta JK, Lin CH, Chen Q. Flow dynamics and characterization of a cough’, Indoor Air 2009; 19: 517-25. [Crossref]
- 20. Gupta JK, Lin C, Chen QY. Characterizing exhaled airflow from breathing and talking. Indoor Air 2010; 20: 31-9. [Crossref]
- 21. Duguid JP. The size and the duration of air-carriage of respiratory droplets and droplet-nuclei. J. Hyg 1946; 44: 471-9. [Crossref]
- 22. Fennelly KP, Martyny JW, Fulton KE, et al. Cough-generated aerosols of Mycobacterium tuberculosis - A new method to study infectiousness. Am J Resp Crit Care 2004; 169: 604-9. [Crossref]
- 23. Yang SH, Lee GWM, Chen CM, et al. The size and concentration of droplets generated by coughing in human subjects J Aerosol Med 2007; 20: 484-94. [Crossref]
- 24. Johnson GR, Morawska L. The Mechanism of Breath Aerosol Formation. J Aerosol Med Pulm D 2009; 22: 229-37. [Crossref]
- 25. Buckland FE, Tyrrell DA. Experiments on spread of colds: 1. Laboratory studies on dispersal of nasal secretion. J Hyg 1964; 62: 365-77. [Crossref]
- 26. Nicas M, Nazaroff W, Hubbar A. Toward understanding the risk of secondary airborne infection: Emission of respirable pathogens. J Occup Environ Hyg 2005; 2: 143-54. [Crossref]
- 27. Gralton J, Tovey E, McLaws ML, et al. The role of particle size in aerosolised pathogen transmission: A review. J Infection 2011; 62: 1-13. [Crossref]
- 28. Chao CYH, Wan MP, Morawska L, et al. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening J Aerosol Sci 2009; 40: 122-33. [Crossref]
- 29. Xie XJ, Li YG, Sun HQ, et al. Exhaled droplets due to talking and coughing J R Soc Interface 2009; 6: S703-14. [Crossref]
- 30. Edwards DA, Man JC, Brand P, et al. Inhaling to mitigate exhaled bioaerosols P Natl Acad Sci USA 200; 101: 17383-8. [Crossref]
- 31. Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza Virus in Human Exhaled Breath: An Observational Study Plos One 2008; 3: e2691. [Crossref]
- 32. Wainwright CE, France MW, O’Rourke P, et al. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax 2009; 64: 926-31. [Crossref]
- 33. Almstrand AC, Bake B, Ljungstrom E, et al. Effect of airway opening on production of exhaled particles J Appl Physiol 2010; 108: 584-8. [Crossref]
- 34. Haslbeck K, Schwarz K, Hohlfeld JM, et al. Submicron droplet formation in the human lung. J Aerosol Sci 2010; 41: 429-38. [Crossref]
- 35. Holmgren H, Ljungstrom E, Almstrand AC, et al. Size distribution of exhaled particles in the range from 0.01 to 2.0 mu m. J Aerosol Sci 2010; 41: 439-46. [Crossref]
- 36. Morawska L, Johnson GR, Ristovski ZD, et al. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. J Aerosol Sci 2009; 40: 256-69. [Crossref]
- 37. Fabian P, Brain J, Houseman EA, et al. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J Aerosol Med Pulm D 2011; 24: 137-47. [Crossref]
- 38. Xie X, Li Y, Chwang ATY, et al. How far droplets can move in indoor environments - revisiting the Wells evaporation-falling curve Indoor Air 2007; 17: 211-25. [Crossref]
- 39. Wells WF. On air-borne infection: Study II. Droplets and droplet nuclei. Am J Hyg 1934; 20: 611-8. [Crossref]
- 40. MacIntyre CR, Chughtai AA, Seale H, et al. Respiratory protection for healthcare workers treating Ebola virus disease (EVD): Are facemasks sufficient to meet occupational health and safety obligations?. Int J Nurs Stud 2014; 51: 1421-6. [Crossref]
- 41. Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola Viruses: What we know and what we do not know. mBio 2015; 6: e01154. [Crossref]
- 42. Shuchman M. Improving protection for Ebola workers. Can Med Assoc J 2015; 187: E85-6. [Crossref]
- 43. Delamou A, Beavogui AH, Konde MK, et al. Ebola: better protection needed for Guinean health-care workers. Lancet 2015; 385: 503-4. [Crossref]
- 44. Perez-Garza J, Garcia S, Heredia N. Removal of Escherichia coli and Enterococcus faecalis after hand washing with antimicrobial and nonantimicrobial soap and persistence of these bacteria in rinsates. J Food Protect 2017; 80: 1670-5. [Crossref]
- 45. Larson EL, Lin SX, Gomez-Pichardo C, et al. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms - A randomized, double-blind trial. Ann Intern Med 2004; 140: 321-9. [Crossref]
- 46. Rabie T, Curti V. Handwashing and risk of respiratory infections: a quantitative systematic review. Trop Med Int Health 2006; 11: 258-67. [Crossref]
- 47. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households A Cluster Randomized Trial. Ann Intern Med 2009; 151: 437-W144. [Crossref]
- 48. Maclntyre CR, Cauchemez S, Dwyer DE, et al. Face Mask Use and Control of Respiratory Virus Transmission in Households Emerg Infect Dis 2009; 15: 233-41. [Crossref]
- 49. Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing Influenza among health care workers a randomized trial. JAMA 2009; 302: 1865-71. [Crossref]
- 50. Atrie D, Worster A. Surgical mask versus N95 respirator for preventing influenza among health care workers: a randomized trial. Can J Emerg Med 2012; 14: 50-2. [Crossref]
- 51. Maines TR, Jayarama A, Belser JA, et al. Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice. Science 2009; 325: 484-7. [Crossref]
- 52. Tellier R. Transmission of influenza A in human beings’, Lancet Infect Dis 2007; 7: 759-60. [Crossref]
- 53. Lee RV.Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7: 760-1. [Crossref]
- 54. Tang JW, Li G. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7: 758. [Crossref]
- 55. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7: 257-65. [Crossref]
- 56. Naik AD, Issac TT, Street RL, et al. Understanding the quality chasm for hypertension control in diabetes: A structured review of “Co-maneuvers” used in clinical trials. J Am Board Fam Med 2007; 20: 469-78. [Crossref]
- 57. Roland M, Torgerson DJ. Clinical review: understanding controlled trials: what are pragmatic trials?. BMJ 1998; 316: 285. [Crossref]
- 58. MacIntyre CR, Chughtai AA, Rahma B, et al. The efficacy of medical masks and respirators against respiratory infection in healthcare workers’. Influenza Other Resp 2017; 11: 511-7. [Crossref]
- 59. Jacobs JL, Ohde S, Takahashi O, et al. Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: A randomized controlled trial. Am J Infect Control 2009; 37: 417-9. [Crossref]
- 60. MacIntyre CR, Wang QY, Cauchemez S, et al. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Resp 2011; 5: 170-9. [Crossref]
- 61. MacIntyre CR, Wang QY, Seale H, et al. A Randomized Clinical Trial of Three Options for N95 Respirators and Medical Masks in Health Workers. Am J Resp Crit Care 2013; 187: 960-6. [Crossref]
- 62. MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015; 5: e006577. [Crossref]
- 63. Shine KI, Rogers B, Goldfrank LR. Novel H1N1 Influenza and Respiratory Protection for Health Care Workers. New Engl J Med 2009; 361: 1823-5. [Crossref]
- 64. Balazy A, Toivola M, Adhikari A, et al. Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? Am J Infect Control 2006; 34: 51-7. [Crossref]
- 65. Lawrence RB, Duling MG, Calvert CA, et al. Comparison of performance of three different types of respiratory protection devices. J Occup Environ Hyg 2006; 3: 465-74. [Crossref]
- 66. Weber A, Willeke K, Marchioni R, et al. Aerosol penetration and leakage characteristics of masks used in the health-care industry. Am J Infect Control 1993; 21: 167-73. [Crossref]
- 67. Sellden E. Is routine use of a face mask necessary in the operating room? Anesthesiology 2010; 113: 1447. [Crossref]
- 68. Mitchell NJ, Hunt S. Surgical face masks in modern operating-rooms - a costly and unnecessary ritual. J Hosp Infect 1991; 18: 239-42. [Crossref]
- 69. Tunevall TG, Bessey PQ. Postoperative wound infections and surgical face masks - a controlled-study. World J Surg 1991; 15: 383-8. [Crossref]
- 70. Palen TE, Felix KG. Surgical masks vs N95 respirators for preventing influenza. JAMA 2010; 303: 937. [Crossref]
- 71. Feng S, Shen C, Xia N, et al. Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med 2020; 8: 434-6. [Crossref]
- 72. Does Wearing a Mask Protect You from the Flu and Other Viruses? Healthline, 2020. Available From: URL: https://www.healthline.com/health/cold-flu/mask
- 73. COVID-19 (novel coronavirus) - face mask and hygiene advice. Ministry of Health Manatū Hauora, 2020. Available From: URL: https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-novel-coronavirus-health-advice-general-public/covid-19-novel-coronavirus-face-mask-and-hygiene-advice
| APA | Vo T, Tran Thi Thu Ngoc V, Vo T (2020). Coronavirus Infection Prevention by Wearing Masks. , 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| Chicago | Vo Thi Sinh,Tran Thi Thu Ngoc Vo,Vo Tran Thi Bich Chau Coronavirus Infection Prevention by Wearing Masks. (2020): 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| MLA | Vo Thi Sinh,Tran Thi Thu Ngoc Vo,Vo Tran Thi Bich Chau Coronavirus Infection Prevention by Wearing Masks. , 2020, ss.197 - 201. 10.5152/eurasianjmed.2020.20056 |
| AMA | Vo T,Tran Thi Thu Ngoc V,Vo T Coronavirus Infection Prevention by Wearing Masks. . 2020; 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| Vancouver | Vo T,Tran Thi Thu Ngoc V,Vo T Coronavirus Infection Prevention by Wearing Masks. . 2020; 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| IEEE | Vo T,Tran Thi Thu Ngoc V,Vo T "Coronavirus Infection Prevention by Wearing Masks." , ss.197 - 201, 2020. 10.5152/eurasianjmed.2020.20056 |
| ISNAD | Vo, Thi Sinh vd. "Coronavirus Infection Prevention by Wearing Masks". (2020), 197-201. https://doi.org/10.5152/eurasianjmed.2020.20056 |
| APA | Vo T, Tran Thi Thu Ngoc V, Vo T (2020). Coronavirus Infection Prevention by Wearing Masks. Eurasian Journal of Medicine, 52(2), 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| Chicago | Vo Thi Sinh,Tran Thi Thu Ngoc Vo,Vo Tran Thi Bich Chau Coronavirus Infection Prevention by Wearing Masks. Eurasian Journal of Medicine 52, no.2 (2020): 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| MLA | Vo Thi Sinh,Tran Thi Thu Ngoc Vo,Vo Tran Thi Bich Chau Coronavirus Infection Prevention by Wearing Masks. Eurasian Journal of Medicine, vol.52, no.2, 2020, ss.197 - 201. 10.5152/eurasianjmed.2020.20056 |
| AMA | Vo T,Tran Thi Thu Ngoc V,Vo T Coronavirus Infection Prevention by Wearing Masks. Eurasian Journal of Medicine. 2020; 52(2): 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| Vancouver | Vo T,Tran Thi Thu Ngoc V,Vo T Coronavirus Infection Prevention by Wearing Masks. Eurasian Journal of Medicine. 2020; 52(2): 197 - 201. 10.5152/eurasianjmed.2020.20056 |
| IEEE | Vo T,Tran Thi Thu Ngoc V,Vo T "Coronavirus Infection Prevention by Wearing Masks." Eurasian Journal of Medicine, 52, ss.197 - 201, 2020. 10.5152/eurasianjmed.2020.20056 |
| ISNAD | Vo, Thi Sinh vd. "Coronavirus Infection Prevention by Wearing Masks". Eurasian Journal of Medicine 52/2 (2020), 197-201. https://doi.org/10.5152/eurasianjmed.2020.20056 |
